Transgenic strains modeling aspects of PD and AD, such as those overexpressing tyrosine hydroxylase in dopaminergic neurons (PD-related) [11, 12] or pro-aggregation tau fragments (AD-related) [13], provide insights into the molecular mechanisms underlying these disorders. This evidence concerns the gene MAPT and Alzheimer disease.